Valproic acid treatment from the 4-cell stage improves oct4 expression and nuclear distribution of histone H3k27me3 in mouse cloned blastocysts

Journal of Reproduction and Development

Volumn 59, Issue 2, 2013, Pages 196-204

  Isaji, Yuuki ^a   Murata, Moeko ^a   Takaguchi, Naoya ^a   Mukai, Toshita ^a   Tajima, Yosuke ^a   Imai, Hiroshi ^a   Yamada, Masayasu ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

H3K27me3; Mouse; Oct4; Somatic cell nuclear transfer; Valproic acid

Indexed keywords

EID: 84876578768     PISSN: 09168818     EISSN: 13484400     Source Type: Journal    
DOI: 10.1262/jrd.2012-156     Document Type: Article

References (61)

1. Wilmut I, Schnieke AE, McWhir J, Kind AJ, Campbell KHS. Viable offspring derived from fetal and adult mammalian cells. Nature 1997; 385: 810-813.
2. Wakayama T, Perry ACF, Zuccotti M, Johnson KR, Yanagimachi R. Full-term development of mice from enucleated oocytes injected with cumulus cell nuclei. Nature 1998; 394: 369-374.
3. Thuan N V, Kishigami S, Wakayama T. How to improve the success rate of mouse cloning technology. J Reprod Dev 2010; 56: 20-30.
4. Wakayama T. Production of cloned mice and ES cells from adult somatic cells by nuclear transfer: how to improve cloning efficiency? J Reprod Dev 2007; 53: 13-26.
5. Kishigami S, Mizutani E, Ohta H, Hikichi T, Van Thuan N, Wakayama S, Bui HT, Wakayama T. Significant improvement of mouse cloning technique by treatment with trichostatin A after somatic nuclear transfer. Biochem Biophys Res Commun 2006; 340: 183-189.
6. Maalouf WE, Liu Z, Brochard V, Renard J P, Debey P, Beaujean N, Zink D. Tricho-statin A treatment of cloned mouse embryos improves constitutive heterochromatin remodeling as well as developmental potential to term. BMC Dev Biol 2009; 9: 11.
7. Costa-Borges N, Santaló J, Ibáñez E. Comparison between the effects of valproic acid and trichostatin A on the in vitro development, blastocyst quality, and full-term development of mouse somatic cell nuclear transfer embryos. Cell Reprogram 2010; 12: 437-446.
8. Rybouchkin A, Kato Y, Tsunoda Y. Role of histone acetylation in reprogramming of somatic nuclei following nuclear transfer. Biol Reprod 2006; 74: 1083-1089.
9. Ono T, Li C, Mizutani E, Terashita Y, Yamagata K, Wakayama T. Inhibition of class IIb histone deacetylase significantly improves cloning efficiency in mice. Biol Reprod 2010; 83: 929-937.
10. Tsuji Y, Kato Y, Tsunoda Y. The developmental potential of mouse somatic cell nuclear-transferred oocytes treated with trichostatin A and 5-aza-2'-deoxycytidine. Zygote 2009; 17: 109-115.
11. Kishigami S, Bui HT, Wakayama S, Tokunaga K, Van Thuan N, Hikichi T, Mizutani E, Ohta H, Suetsugu R, Sata T, Wakayama T. Successful mouse cloning of an outbred strain by trichostatin A treatment after somatic nuclear transfer. J Reprod Dev 2007; 53: 165-170.
12. Van Thuan N, Bui HT, Kim JH, Hikichi T, Wakayama S, Kishigami S, Mizutani E, Wakayama T. The histone deacetylase inhibitor scriptaid enhances nascent mRNA production and rescues full-term development in cloned inbred mice. Reproduction 2009; 138: 309-317.
13. Dai X, Hao J, Hou XJ, Hai T, Fan Y, Yu Y, Jouneau A, Wang L, Zhou Q. Somatic nucleus reprogramming is significantly improved by m-carboxycinnamic acid bishydrox-amide, a histone deacetylase inhibitor. J Biol Chem 2010; 285: 31002-31010.
14. Hirata S, Fukasawa H, Tagaya H, Shoda T, Wakayama T, Hoshi K. Effects of sirtinol on early development of the cloned murine embryos. Yamanashi Med J 2008; 23: 97-107.
15. Blackwell L, Norris J, Suto CM, Janzen W P. The use of diversity profiling to characterize chemical modulators of the histone deacetylases. Life Sci 2008; 82: 1050-1058.
16. Chuang DM, Leng Y, Marinova Z, Kim HJ, Chiu CT. Multiple roles of HDAC inhibition in neurodegenerative conditions. Trends Neurosci 2009; 32: 591-601.
17. Kuhn AN, Van Santen MA, Schwienhorst A, Urlaub H, Lührmann R. Stalling of spliceosome assembly at distinct stages by small-molecule inhibitors of protein acetyla-tion and deacetylation. RNA 2009; 15: 153-175.
18. Codd R, Braich N, Liu J, Soe CZ, Pakchung AAH. Zn (II)-dependent histone deacety-lase inhibitors: suberoylanilide hydroxamic acid and trichostatin A. Int J Biochem Cell Biol 2009; 41: 736-739.
19. Mai A, Massa S, Ragno R, Cerbara I, Jesacher F, Loidl P, Brosch G. 3-(4-Aroyl-1-methyl-1H-2-pyrrolyl)-N-hydroxy-2-alkylamides as a new class of synthetic histone deacetylase inhibitors. 1. Design, synthesis, biological evaluation, and binding mode studies performed through three different docking procedures. J Med Chem 2003; 46: 512-524.
20. Miyoshi K, Mori H, Mizobe Y, Akasaka E, Ozawa A, Yoshida M, Sato M. Valproic acid enhances in vitro development and Oct-3/4 expression of miniature pig somatic cell nuclear transfer embryos. Cell Reprogram 2010; 12: 67-74.
21. VerMilyea MD, O'Neill L P, Turner BM. Transcription-independent heritability of induced histone modifications in the mouse preimplantation embryo. PLoS ONE 2009; 4: 9.
22. Palmieri SL, Peter W, Hess H, Schöler HR. Oct-4 transcription factor is differentially expressed in the mouse embryo during establishment of the first two extraembryonic cell lineages involved in implantation. Dev Biol 1994; 166: 259-267.
23. Boiani M, Eckardt S, Schöler HR, McLaughlin KJ. Oct4 distribution and level in mouse clones: consequences for pluripotency. Genes Dev 2002; 16: 1209-1219.
24. Bortvin A, Eggan K, Skaletsky H, Akutsu H, Berry DL, Yanagimachi R, Page DC, Jaenisch R. Incomplete reactivation of Oct4-related genes in mouse embryos cloned from somatic nuclei. Development 2003; 130: 1673-1680.
25. Boiani M, Gentile L, Gambles V V, Cavaleri F, Redi CA, Schöler HR. Variable re-programming of the pluripotent stem cell marker Oct4 in mouse clones: distinct developmental potentials in different culture environments. Stem Cells 2005; 23: 1089-1104.
26. Kishigami S, Hikichi T, Van Thuan N, Ohta H, Wakayama S, Bui HT, Mizutani E, Wakayama T. Normal specification of the extraembryonic lineage after somatic nuclear transfer. FEBS Lett 2006; 580: 1801-1806.
27. Nichols J, Zevnik B, Anastassiadis K, Niwa H, Klewe-Nebenius D, Chambers I, Scho-ler H, Smith A. Formation of pluripotent stem cells in the mammalian embryo depends on the POU transcription factor Oct4. Cell 1998; 95: 379-391.
28. Inoue K, Kohda T, Sugimoto M, Sado T, Ogonuki N, Matoba S, Shiura H, Ikeda R, Mochida K, Fujii T, Sawai K, Otte A P, Tian XC, Yang X, Ishino F, Abe K, Ogura A. Impeding Xist expression from the active X chromosome improves mouse somatic cell nuclear transfer. Science 2010; 330: 496-499.
29. Nolen LD, Gao S, Han Z, Mann M R W, Gie Chung Y, Otte A P, Bartolomei MS, Latham KE. X chromosome reactivation and regulation in cloned embryos. Dev Biol 2005; 279: 525-540.
30. Bao S, Miyoshi N, Okamoto I, Jenuwein T, Heard E, Azim Surani M. Initiation of epigenetic reprogramming of the X chromosome in somatic nuclei transplanted to a mouse oocyte. EMBO Rep 2005; 6: 748-754.
31. Eggan K, Akutsu H, Hochedlinger K, Rideout W, Yanagimachi R, Jaenisch R. X-Chromosome inactivation in cloned mouse embryos. Science 2000; 290: 1578-1581.
32. Senda S, Wakayama T, Yamazaki Y, Ohgane J, Hattori N, Tanaka S, Yanagimachi R, Shiota K. Skewed X-inactivation in cloned mice. Biochem Biophys Res Commun 2004; 321: 38-44.
33. Brockdorff N, Ashworth A, Kay G F, Cooper P, Smith S, McCabe VM, Norris D P, Penny GD, Patel D, Rastan S. Conservation of position and exclusive expression of mouse Xist from the inactive X chromosome. Nature 1991; 351: 329-331.
34. Brown CJ, Ballabio A, Rupert JL, Lafreniere RG, Grompe M, Tonlorenzi R, Willard H F. A gene from the region of the human X chromosome inactivation centre is expressed exclusively from the inactive X chromosome. Nature 1991; 349: 38-44.
35. Borsani G, Tonlorenzi R, Simmler MC, Dandolo L, Arnaud D, Capra V, Grompe M, Pizzuti A, Muzny D, Lawrence C, Willard H F, Avner P, Ballabio A. Characterization of a murine gene expressed from the inactive X chromosome. Nature 1991; 351: 325-329.
36. Plath K, Fang J, Mlynarczyk-Evans SK, Cao R, Worringer KA, Wang H, De La Cruz CC, Otte A P, Panning B, Zhang Y. Role of histone H3 lysine 27 methylation in X inactivation. Science 2003; 300: 131-135.
37. Kohlmaier A, Savarese F, Lachner M, Martens J, Jenuwein T, Wutz A. A chromosomal memory triggered by Xist regulates histone methylation in X inactivation. PLoS Biol 2004; 2: e171.
38. Rougeulle C, Chaumeil J, Sarma K, Allis CD, Reinberg D, Avner P, Heard E. Differential histone H3 Lys-9 and Lys-27 methylation profiles on the X chromosome. Mol Cell Biol 2004; 24: 5475-5484.
39. Keohane AM, Barlow AL, Waters J, Bourn D, Turner BM. H4 acetylation, XIST RNA and replication timing are coincident and define x;autosome boundaries in two abnormal X chromosomes. Hum Mol Genet 1999; 8: 377-383.
40. Donohoe ME, Silva SS, Pinter S F, Xu N, Lee JT. The pluripotency factor Oct4 interacts with Ctcf and also controls X-chromosome pairing and counting. Nature 2009; 460: 128-132.
41. Navarro P, Chambers I, Karwacki-Neisius V, Chureau C, Morey C, Rougeulle C, Avner P. Molecular coupling of Xist regulation and pluripotency. Science 2008; 321: 1693-1695.
42. Navarro P, Oldfeld A, Legoupi J, Festuccia N, Dubois A, Attia M, Schoorlemmer J, Rougeulle C, Chambers I, Avner P. Molecular coupling of Tsix regulation and pluripo-tency. Nature 2010; 468: 457-460.
43. Navarro P, Avner P. When X-inactivation meets pluripotency: an intimate rendezvous. FEBS Letters 2009; 583: 1721-1727.
44. Erwin JA, Del Rosario B, Payer B, Lee JT. An ex vivo model for imprinting: mutually exclusive binding of Cdx2 and Oct4 as a switch for imprinted and random X-inactivation. Genetics 2012; 192; 857-868.
45. Kimura Y, Yanagimachi R. Intracytoplasmic sperm injection in the mouse. Biol Reprod 1995; 52: 709-720.
46. Ho Y, Wigglesworth K, Eppig JJ, Schultz RM. Preimplantation development of mouse embryos in KSOM: augmentation by amino acids and analysis of gene expression. Mol Reprod Dev 1995; 41: 232-238.
47. Suzuki T, Minami N, Kono T, Imai H. Zygotically activated genes are suppressed in mouse nuclear transferred embryos. Cloning Stem Cells 2006; 8: 295-304.
48. Choi YH, Toyoda Y. Cyclodextrin removes cholesterol from mouse sperm and induces capacitation in a protein-free medium. Biol Reprod. 1998; 59: 1328-1333.
49. Ohta H, Sakaide Y, Wakayama T. Generation of mice derived from embryonic stem cells using blastocysts of different developmental ages. Reproduction 2008; 136: 581-587.
50. Su J, Wang Y, Li Y, Li R, Li Q, Wu Y, Quan F, Liu J, Guo Z, Zhang Y. Oxamfatin significantly improves nuclear reprogramming, blastocyst quality, and in vitro development of bovine SCNT embryos. PLoS One 2011; 6: e23805.
51. Davie JR. Inhibition of histone deacetylase activity by butyrate. J Nutr 2003; 133: 2485S-2493S.
52. Humpherys D, Eggan K, Akutsu H, Friedman A, Hochedlinger K, Yanagimachi R, Lander ES, Golub TR, Jaenisch R. Abnormal gene expression in cloned mice derived from embryonic stem cell and cumulus cell nuclei. Proc Natl Acad Sci USA 2002; 99: 12889-12894.
53. Inoue K, Kohda T, Lee J, Ogonuki N, Mochida K, Noguchi Y, Tanemura K, Kaneko-Ishino T, Ishino F, Ogura A. Faithful expression of imprinted genes in cloned mice. Science 2002; 295: 297.
54. Ohgane J, Wakayama T, Senda S, Yamazaki Y, Inoue K, Ogura A, Marh J, Tanaka S, Yanagimachi R, Shiota K. The Sall3 locus is an epigenetic hotspot of aberrant DNA methylation associated with placentomegaly of cloned mice. Genes Cells 2004; 9: 253-260.
55. Wang F, Kou Z, Zhang Y, Gao S. Dynamic reprogramming of histone acetylation and methylation in the frst cell cycle of cloned mouse embryos. Biol Reprod 2007; 77: 1007-1016.
56. Williams RSB, Cheng L, Mudge AW, Harwood AJ. A common mechanism of action for three mood-stabilizing drugs. Nature 2002; 417: 292-295.
57. Kelly K F, Ng D Y, Jayakumaran G, Wood GA, Koide H, Doble B W. β-catenin enhances Oct-4 activity and reinforces pluripotency through a TCF-independent mechanism. Cell Stem Cell 2011; 8: 214-227.
58. Li J, Li J, Chen B. Oct4 was a novel target of Wnt signaling pathway. Mol Cell Biochem 2012; 362: 233-240.
59. Aparicio IM, Garcia-Herreros M, Fair T, Lonergan P. Identification and regulation of glycogen synthase kinase-3 during bovine embryo development. Reproduction 2010; 140: 83-92.
60. Okamoto I, Otte A P, Allis CD, Reinberg D, Heard E. Epigenetic dynamics of imprinted X inactivation during early mouse development. Science 2004; 303: 644-649.
61. Patrat C, Okamoto I, Diabangouaya P, Vialon V, Le Baccon P, Chow J, Heard E. Dynamic changes in paternal X-chromosome activity during imprinted X-chromosome in-activation in mice. Proc Natl Acad Sci USA 2009; 106: 5198-5203.